Literature DB >> 26890680

Study of in vivo catheter biofilm infections using pediatric central venous catheter implanted in rat.

Ashwini Chauhan1, Jean-Marc Ghigo1, Christophe Beloin1.   

Abstract

Venous access catheters used in clinics are prone to biofilm contamination, contributing to chronic and nosocomial infections. Although several animal models for studying device-associated biofilms were previously described, only a few detailed protocols are currently available. Here we provide a protocol using totally implantable venous access ports (TIVAPs) implanted in rats. This model recapitulates all phenomena observed in the clinic, and it allows bacterial biofilm development and physiology to be studied. After TIVAP implantation and inoculation with luminescent pathogens, in vivo biofilm formation can be monitored in situ, and biofilm biomass can be recovered from contaminated TIVAP and organs. We used this protocol to study host responses to biofilm infection, to evaluate preventive and curative antibiofilm strategies and to study fundamental biofilm properties. For this procedure, one should expect ∼3 h of hands-on time, including the implantation in one rat followed by in situ luminescence monitoring and bacterial load estimation.

Entities:  

Mesh:

Year:  2016        PMID: 26890680     DOI: 10.1038/nprot.2016.033

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  48 in total

1.  Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy.

Authors:  Ashwini Chauhan; David Lebeaux; Jean-Marc Ghigo; Christophe Beloin
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

2.  Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.

Authors:  Jorge Parra-Ruiz; Celine Vidaillac; Warren E Rose; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

3.  Statistical assessment of a laboratory method for growing biofilms.

Authors:  Darla M Goeres; Linda R Loetterle; Martin A Hamilton; Ricardo Murga; Douglas W Kirby; Rodney M Donlan
Journal:  Microbiology (Reading)       Date:  2005-03       Impact factor: 2.777

4.  Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin.

Authors:  Reuben Ramphal; Viviane Balloy; Jeevan Jyot; Amrisha Verma; Mustapha Si-Tahar; Michel Chignard
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

5.  Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.

Authors:  John F Kokai-Kun; Tanya Chanturiya; James J Mond
Journal:  J Antimicrob Chemother       Date:  2009-04-27       Impact factor: 5.790

6.  Direct continuous method for monitoring biofilm infection in a mouse model.

Authors:  Jagath L Kadurugamuwa; Lin Sin; Eddie Albert; Jun Yu; Kevin Francis; Monica DeBoer; Michael Rubin; Carole Bellinger-Kawahara; T R Parr; Pamela R Contag
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

7.  Development of real-time in vivo imaging of device-related Staphylococcus epidermidis infection in mice and influence of animal immune status on susceptibility to infection.

Authors:  Cuong Vuong; Stanislava Kocianova; Jun Yu; Jagath L Kadurugamuwa; Michael Otto
Journal:  J Infect Dis       Date:  2008-07-15       Impact factor: 5.226

8.  The alternative sigma factor sigma B of Staphylococcus aureus modulates virulence in experimental central venous catheter-related infections.

Authors:  Udo Lorenz; Christian Hüttinger; Tina Schäfer; Wilma Ziebuhr; Arnulf Thiede; Jörg Hacker; Susanne Engelmann; Michael Hecker; Knut Ohlsen
Journal:  Microbes Infect       Date:  2007-11-28       Impact factor: 2.700

9.  Biofilms formed by gram-negative bacteria undergo increased lipid a palmitoylation, enhancing in vivo survival.

Authors:  Sabina Chalabaev; Ashwini Chauhan; Alexey Novikov; Pavithra Iyer; Magdalena Szczesny; Christophe Beloin; Martine Caroff; Jean-Marc Ghigo
Journal:  mBio       Date:  2014-08-19       Impact factor: 7.867

Review 10.  From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.

Authors:  David Lebeaux; Ashwini Chauhan; Olaya Rendueles; Christophe Beloin
Journal:  Pathogens       Date:  2013-05-13
View more
  7 in total

Review 1.  Options and Limitations in Clinical Investigation of Bacterial Biofilms.

Authors:  Maria Magana; Christina Sereti; Anastasios Ioannidis; Courtney A Mitchell; Anthony R Ball; Emmanouil Magiorkinis; Stylianos Chatzipanagiotou; Michael R Hamblin; Maria Hadjifrangiskou; George P Tegos
Journal:  Clin Microbiol Rev       Date:  2018-04-04       Impact factor: 26.132

Review 2.  Anti-fouling strategies for central venous catheters.

Authors:  Alex Wallace; Hassan Albadawi; Nikasha Patel; Ali Khademhosseini; Yu Shrike Zhang; Sailendra Naidu; Grace Knuttinen; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 3.  Phenazine Antibiotic-Inspired Discovery of Bacterial Biofilm-Eradicating Agents.

Authors:  Robert W Huigens; Yasmeen Abouelhassan; Hongfen Yang
Journal:  Chembiochem       Date:  2019-10-02       Impact factor: 3.164

4.  Effect of Biosynthesized Silver Nanoparticles on Bacterial Biofilm Changes in S. aureus and E. coli.

Authors:  Bozena Hosnedlova; Daniil Kabanov; Marta Kepinska; Vedha Hari B Narayanan; Arli Aditya Parikesit; Carlos Fernandez; Geir Bjørklund; Hoai Viet Nguyen; Awais Farid; Jiri Sochor; Agnes Pholosi; Mojmir Baron; Milan Jakubek; Rene Kizek
Journal:  Nanomaterials (Basel)       Date:  2022-06-25       Impact factor: 5.719

5.  Exploiting Interkingdom Interactions for Development of Small-Molecule Inhibitors of Candida albicans Biofilm Formation.

Authors:  F Jerry Reen; John P Phelan; Lorna Gallagher; David F Woods; Rachel M Shanahan; Rafael Cano; Eoin Ó Muimhneacháin; Gerard P McGlacken; Fergal O'Gara
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

6.  Assessing in vivo and in vitro biofilm development by Streptococcus dysgalactiae subsp. dysgalactiae using a murine model of catheter-associated biofilm and human keratinocyte cell.

Authors:  Cinthia Alves-Barroco; Ana Maria Nunes Botelho; Marco Antonio Américo; Sérgio Eduardo Longo Fracalanzza; António P Alves de Matos; Márcia Aparecida Guimaraes; Bernadete Teixeira Ferreira-Carvalho; Agnes Marie Sá Figueiredo; Alexandra R Fernandes
Journal:  Front Cell Infect Microbiol       Date:  2022-07-19       Impact factor: 6.073

7.  Speciality Grand Challenge for "Biofilms".

Authors:  Christophe Beloin; Diane McDougald
Journal:  Front Cell Infect Microbiol       Date:  2021-02-22       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.